Long‐term follow‐up of a young male who developed acute macular neuroretinopathy following COVID‐19 vaccination

This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no...

Descripción completa

Detalles Bibliográficos
Autores principales: Ikema, Shunsuke, Miura, Gen, Shimizu, Daisuke, Baba, Takayuki
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10645608/
https://www.ncbi.nlm.nih.gov/pubmed/38028086
http://dx.doi.org/10.1002/ccr3.8181
Descripción
Sumario:This report presents the clinical findings and prognosis of a healthy male patient who developed acute macular neuroretinopathy after COVID‐19 vaccination. Abnormal findings improved about 1 month after the onset and disappeared 3 months later. The subjective symptoms disappeared in 3 months, and no recurrence was observed for 1 year.

Ejemplares similares